Pentaxim® injection – A new 5-in-1 combination vaccine

Editorial Office


This combination vaccine is indicated for active immunisation of infants from six weeks of age against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b (such as meningitis, septicaemia, cellulitis, arthritis, epiglottitis,
pneumopathy and osteomyelitis). The vaccine contains acellular pertussis and inactivated polio vaccine, both of which have been found to be effective and have a better side effect profile.

Full Text:


This journal is hosted by: Medpharm Publications. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 South Africa License